CIK 0000884121
abrdn Life Sciences Investors
Sign in to watch- Ticker
- HQL
- Exchange
- NYSE
- FY end
- Sep 30
- Incorporated
- MA
- Entity type
- other
- EIN
- 043147016
- Phone
- 6177728515
- Business address
- 1900 MARKET STREET, SUITE 200, PHILADELPHIA, PA, 19103
- Former names
- TEKLA LIFE SCIENCES INVESTORS, H&Q LIFE SCIENCES INVESTORS
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,300 shares at $21.04 ($27,348)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at $28.17 ($28,170)
- 4 Option exercise Director acquired 752 shares (option exercise)
- 4 Open-market buy Director bought 200 shares at $19.75 ($3,950)
- 4 Option exercise President acquired 14,688 shares (option exercise)
- 4 Option exercise Director acquired 1,000 shares (option exercise)
- 4 Option exercise Director acquired 578 shares (option exercise)
- 4 Option exercise Director acquired 76 shares (option exercise)
- 4 Option exercise Director acquired 1,459 shares (option exercise)
- 4 Open-market buy President bought 6,000 shares at $17.58 ($105,473)
- 4 Open-market buy Director bought 200 shares at $13.30 ($2,660)
- 4 Open-market buy Director bought 800 shares at $13.25 ($10,604)
- 4 Open-market buy Director bought 772 shares at $13.27 ($10,241)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President bought 10,000 shares at $10.03 ($100,328)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President bought 3,000 shares at an average $8.61 ($25,840)
- 3 Insider Initial Statement of Ownership
Page 6 of 8 · 141 filings